
Gabriele E. Bugaisky
Examiner (ID: 779)
| Most Active Art Unit | 1653 |
| Art Unit(s) | 2899, 2900, 1804, 1634, 1653, 1654, 1643, 1814, 1609, 1652, 1656 |
| Total Applications | 617 |
| Issued Applications | 349 |
| Pending Applications | 104 |
| Abandoned Applications | 164 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11016692
[patent_doc_number] => 20160213645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'COMBINATION OF LEVETIRACETAM AND A BETA-SECRETASE (BACE) INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 15/089563
[patent_app_country] => US
[patent_app_date] => 2016-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4024
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15089563
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/089563 | COMBINATION OF LEVETIRACETAM AND A BETA-SECRETASE (BACE) INHIBITOR | Apr 2, 2016 | Abandoned |
Array
(
[id] => 16229342
[patent_doc_number] => 10736871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Anti-methanogenic lovastatin analogs or derivatives and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/560145
[patent_app_country] => US
[patent_app_date] => 2016-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 31851
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560145
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/560145 | Anti-methanogenic lovastatin analogs or derivatives and uses thereof | Mar 30, 2016 | Issued |
Array
(
[id] => 12699724
[patent_doc_number] => 20180125074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => PESTICIDAL COMPOSITIONS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 15/563933
[patent_app_country] => US
[patent_app_date] => 2016-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13507
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563933
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/563933 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | Mar 29, 2016 | Abandoned |
Array
(
[id] => 11090593
[patent_doc_number] => 20160287562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'METHOD FOR THE TREATMENT OF NF1- OR RAS-ASSOCIATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/084129
[patent_app_country] => US
[patent_app_date] => 2016-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6678
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15084129
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/084129 | Method for the treatment of NF1- or RAS-associated disorders | Mar 28, 2016 | Issued |
Array
(
[id] => 12701917
[patent_doc_number] => 20180125805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => PROPHYLACTIC/THERAPEUTIC AGENT FOR VIRUS INFECTIONS WHICH COMPRISES ALA COMPOUND
[patent_app_type] => utility
[patent_app_number] => 15/564210
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15564210
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/564210 | PROPHYLACTIC/THERAPEUTIC AGENT FOR VIRUS INFECTIONS WHICH COMPRISES ALA COMPOUND | Mar 17, 2016 | Abandoned |
Array
(
[id] => 11075648
[patent_doc_number] => 20160272612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'ANTHROPOD REPELLENT CHEMICALS'
[patent_app_type] => utility
[patent_app_number] => 15/073698
[patent_app_country] => US
[patent_app_date] => 2016-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 7114
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15073698
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/073698 | ANTHROPOD REPELLENT CHEMICALS | Mar 17, 2016 | Abandoned |
Array
(
[id] => 13586347
[patent_doc_number] => 20180344722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => Combination of Oxymetazoline and Ipratropium in Topical Nasal Application for the Treatment of a Cough
[patent_app_type] => utility
[patent_app_number] => 15/778067
[patent_app_country] => US
[patent_app_date] => 2016-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778067
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778067 | Combination of oxymetazoline and ipratropium in topical nasal application for the treatment of a cough | Mar 16, 2016 | Issued |
Array
(
[id] => 11067617
[patent_doc_number] => 20160264582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => '(Indazol-4-YL) Hexahydropyrrolopyrrolones and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 15/069195
[patent_app_country] => US
[patent_app_date] => 2016-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56164
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15069195
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/069195 | (Indazol-4-yl) hexahydropyrrolopyrrolones and methods of use | Mar 13, 2016 | Issued |
Array
(
[id] => 11066162
[patent_doc_number] => 20160263126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'COMPOSITIONS AND THERAPEUTIC METHODS FOR THE TREATMENT OF COMPLEMENT-ASSOCIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/066513
[patent_app_country] => US
[patent_app_date] => 2016-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17910
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15066513
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/066513 | Compositions and therapeutic methods for the treatment of complement-associated diseases | Mar 9, 2016 | Issued |
Array
(
[id] => 11025043
[patent_doc_number] => 20160221999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/061961
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 32084
[patent_no_of_claims] => 233
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15061961
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/061961 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS | Mar 3, 2016 | Abandoned |
Array
(
[id] => 17206913
[patent_doc_number] => 11167264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-09
[patent_title] => Packing material for liquid chromatography
[patent_app_type] => utility
[patent_app_number] => 15/556384
[patent_app_country] => US
[patent_app_date] => 2016-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 9483
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556384
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/556384 | Packing material for liquid chromatography | Mar 2, 2016 | Issued |
Array
(
[id] => 12343419
[patent_doc_number] => 09949970
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Synthesis of new benzothiazole derivatives as potential anti-tubercular agents
[patent_app_type] => utility
[patent_app_number] => 15/057718
[patent_app_country] => US
[patent_app_date] => 2016-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6172
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15057718
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/057718 | Synthesis of new benzothiazole derivatives as potential anti-tubercular agents | Feb 29, 2016 | Issued |
Array
(
[id] => 11052659
[patent_doc_number] => 20160249621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'COMPOSITION CONTAINING AN ORGANOSILANE AND A PHOTOCATALYST, AND METHODS OF TREATING FLOWERING PLANTS INFECTED WITH A BACTERIAL DISEASE USING THE COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/055198
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4426
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15055198
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/055198 | Composition containing an organosilane and a photocatalyst, and methods of treating flowering plants infected with a bacterial disease using the composition | Feb 25, 2016 | Issued |
Array
(
[id] => 11047491
[patent_doc_number] => 20160244449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/047892
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59198
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15047892
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/047892 | Bicyclic heterocycles as FGFR4 inhibitors | Feb 18, 2016 | Issued |
Array
(
[id] => 11038113
[patent_doc_number] => 20160235070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'FUNGICIDAL COMPOUNDS AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/040388
[patent_app_country] => US
[patent_app_date] => 2016-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7974
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15040388
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/040388 | Fungicidal compounds and compositions | Feb 9, 2016 | Issued |
Array
(
[id] => 11034354
[patent_doc_number] => 20160231311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'METABOLIC MARKERS OF ATTENTION DEFICIT HYPERACTIVITY DISORDER'
[patent_app_type] => utility
[patent_app_number] => 15/019258
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5319
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15019258
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/019258 | Metabolic markers of attention deficit hyperactivity disorder | Feb 8, 2016 | Issued |
Array
(
[id] => 11018022
[patent_doc_number] => 20160214976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'CRYSTALLINE AND AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 15/005674
[patent_app_country] => US
[patent_app_date] => 2016-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6793
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15005674
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/005674 | CRYSTALLINE AND AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE | Jan 24, 2016 | Abandoned |
Array
(
[id] => 10782829
[patent_doc_number] => 20160128985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'Methods and Compositions for the Treatment of Body Weight Related Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/991518
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 31967
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14991518
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/991518 | Methods and Compositions for the Treatment of Body Weight Related Disorders | Jan 7, 2016 | Abandoned |
Array
(
[id] => 12150077
[patent_doc_number] => 20180021341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'ACC INHIBITOR COMBINATION THERAPY FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/541008
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15320
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541008
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541008 | ACC INHIBITOR COMBINATION THERAPY FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | Jan 7, 2016 | Abandoned |
Array
(
[id] => 11574125
[patent_doc_number] => 09629362
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-04-25
[patent_title] => 'Methods for killing insects using methyl benzoate'
[patent_app_type] => utility
[patent_app_number] => 14/988090
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6386
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988090
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/988090 | Methods for killing insects using methyl benzoate | Jan 4, 2016 | Issued |